Hemostemix Inc.
HEM.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -51.65% | 5.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -51.37% | 5.39% | |||
| Operating Income | 51.37% | -5.39% | |||
| Income Before Tax | 75.15% | 4.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 75.15% | 4.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.15% | 4.13% | |||
| EBIT | 51.37% | -5.39% | |||
| EBITDA | 51.37% | -5.39% | |||
| EPS Basic | 84.04% | -18.99% | |||
| Normalized Basic EPS | 84.75% | -25.53% | |||
| EPS Diluted | 84.04% | -18.99% | |||
| Normalized Diluted EPS | 84.75% | -25.53% | |||
| Average Basic Shares Outstanding | 54.09% | -20.03% | |||
| Average Diluted Shares Outstanding | 54.09% | -20.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||